SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-103372
Filing Date
2009-05-07
Accepted
2009-05-07 16:16:20
Documents
8
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 302514
2 LICENSE AGREEMENT dex102.htm EX-10.2 213452
3 AMENDED AND RESTATED MANUFACTURING AGREEMENT dex103.htm EX-10.3 66326
4 AMENDED AND RESTATED LICENSE AGREEMENT dex104.htm EX-10.4 189554
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 5702
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 5726
7 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3610
8 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3631
  Complete submission text file 0001193125-09-103372.txt   791950
Mailing Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101
Business Address 1100 OLIVE WAY STE 100 SEATTLE WA 98101 2066237612
TARGETED GENETICS CORP /WA/ (Filer) CIK: 0000921114 (see all company filings)

IRS No.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23930 | Film No.: 09805695
SIC: 2836 Biological Products, (No Diagnostic Substances)